AK Medical Holdings Limited Stock price

Equities

1789

KYG020141019

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
4.92 HKD +1.03% Intraday chart for AK Medical Holdings Limited -5.75% -21.41%

Financials

Sales 2023 1.09B 151M 1.18B Sales 2024 * 1.62B 224M 1.75B Capitalization 5.05B 698M 5.46B
Net income 2023 182M 25.18M 197M Net income 2024 * 316M 43.72M 342M EV / Sales 2023 5.84 x
Net cash position 2023 * 1.07B 149M 1.16B Net cash position 2024 * 773M 107M 836M EV / Sales 2024 * 2.65 x
P/E ratio 2023
35.6 x
P/E ratio 2024 *
15.8 x
Employees 1,052
Yield 2023 *
1.33%
Yield 2024 *
1.56%
Free-Float 48.64%
More Fundamentals * Assessed data
Dynamic Chart
AK Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024 CI
AK Medical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
AK Medical Secures Regulatory Nod For Pelvic Implant MT
Ak Medical Holdings Limited Obtains the Certification from National Medical Products Administration CI
AK Medical Gets Certification for Acetabular Component of Hip Prosthesis MT
AK Medical Holdings Limited Obtains the Certification for Acetabular Component of Hip Prosthesis Class III Medical Devices Approved by the National Medical Products Administration CI
China Grants Certification for AK Medical Holdings' Surgical Robotic Arm MT
AK Medical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
AK Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on or Around 18 July 2023 CI
Chinese Regulator Approves AK Medical's Certification for Prosthetis System MT
AK Medical Holdings Limited Obtains the Certification for the Metal Additive Manufacturing Thoracolumbar Fusion Matching Prosthesis System Class III Medical Devices Approved by the National Medical Products Administration CI
AK Medical’s Bone Reconstruction Medical Device Gets Certification in China MT
AK Medical Holdings Limited Announces Obtaining the Certification for the Trauma Custom Bridge Class III Medical Devices Approved by the National Medical Products Administration CI
AK Medical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023 CI
AK Medical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+1.03%
1 week-5.75%
Current month-3.15%
1 month-2.38%
3 months-21.78%
6 months-27.86%
Current year-21.41%
More quotes
1 week
4.47
Extreme 4.47
5.23
1 month
4.47
Extreme 4.47
5.50
Current year
3.89
Extreme 3.89
6.35
1 year
3.89
Extreme 3.89
11.18
3 years
3.50
Extreme 3.5
16.28
5 years
3.41
Extreme 3.41
27.65
10 years
1.75
Extreme 1.75
27.65
More quotes
Managers TitleAgeSince
Founder 54 15-07-16
Chief Executive Officer 56 15-07-16
Director of Finance/CFO 40 16-11-30
Members of the board TitleAgeSince
Director/Board Member 63 16-02-28
Director/Board Member 49 17-11-16
Chief Executive Officer 56 15-07-16
More insiders
Date Price Change Volume
24-03-28 4.92 +1.03% 3 214 000
24-03-27 4.87 +5.87% 3,562,000
24-03-26 4.6 -2.13% 1,667,000
24-03-25 4.7 -3.49% 2,881,000
24-03-22 4.87 -6.70% 2,984,000

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
AK MEDICAL HOLDINGS LIMITED is a company principally engaged in the design, development, manufacture and distribution of orthopedic implants. The Company has commercialized the application of three dimensional (3D) printing technology in orthopedic joint and spine replacement implants, with a focus on hip and knee replacement implants. The Company's 3D Accurate Construction Technology (ACT) solutions assist surgeons in simulating and planning for implant surgeries, simplify surgical processes, offer personalized surgical instruments and pre-surgery selected implants and improve patients? recovery experience significantly. The Company sells its products mainly within the China market and to oversea markets such as United Kingdom.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.499 CNY
Average target price
8.436 CNY
Spread / Average Target
+87.53%
Consensus
  1. Stock
  2. Equities
  3. Stock AK Medical Holdings Limited - Hong Kong S.E.